Related Experiment Video
Updated: Jun 18, 2026

Polycarbonate Ultracentrifuge Tube Re-Use in Proteomic Analyses of Extracellular Vesicles
Published on: March 8, 2024
Microparticles as biomarkers in autoimmunity: from dust bin to center stage
Abstract:
Microparticles are small membrane-bound vesicles released from activated and dying cells. As shown in a study of primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis, levels of microparticles in the blood, as measured by a solid-phase prothrombinase assay or flow cytometry, are increased with autoimmunity. Among patients with these conditions, however, particle numbers were inversely related to disease activity and levels of the enzyme secretory phospholipase A2 that can digest membrane lipids and perhaps cause particle loss. These findings suggest microparticles as novel biomarkers for autoimmunity, with levels reflecting events leading to their loss as well as production.
Insights
Microparticle levels in blood increase with autoimmune diseases like Sjogren
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Microparticles are vesicles from activated/dying cells.
- Elevated microparticle levels observed in Sjogren's syndrome, lupus, and rheumatoid arthritis.
- Blood microparticle quantification via solid-phase prothrombinase assay or flow cytometry.
Discussion:
- Inverse relationship between microparticle count and disease activity in autoimmune patients.
- Secretory phospholipase A2 may degrade microparticles, influencing observed levels.
- Microparticle levels may reflect both production and degradation processes.
Key Insights:
- Microparticles are potential novel biomarkers for autoimmunity.
- Quantifiable microparticle levels correlate with autoimmune conditions.
- Enzyme activity (secretory phospholipase A2) impacts microparticle levels.
Outlook:
- Further research into microparticle dynamics in autoimmunity is warranted.
- Potential for microparticles as diagnostic or prognostic tools.
- Investigate the role of secretory phospholipase A2 in microparticle homeostasis.
